Arbutus Biopharma Corp. (ABUS)
5.20
-0.01
(-0.19%)
USD |
NASDAQ |
Aug 24, 16:00
5.20
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Gross Profit Margin (Quarterly) : 98.92% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 98.92% |
| March 31, 2026 | 99.99% |
| December 31, 2025 | 98.95% |
| September 30, 2025 | 97.92% |
| June 30, 2025 | 99.90% |
| March 31, 2025 | 81.29% |
| December 31, 2024 | 78.84% |
| September 30, 2024 | 74.91% |
| June 30, 2024 | 79.37% |
| March 31, 2024 | 76.83% |
| December 31, 2023 | 83.26% |
| September 30, 2023 | 92.08% |
| June 30, 2023 | 92.65% |
| March 31, 2023 | 95.01% |
| December 31, 2022 | 95.08% |
| September 30, 2022 | 94.24% |
| June 30, 2022 | 97.31% |
| March 31, 2022 | 96.87% |
| December 31, 2021 | 86.68% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 91.77% |
| March 31, 2014 | 96.98% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | -7.59% |
| Insmed, Inc. | 83.71% |
| Pfizer Inc. | 62.94% |
| Gossamer Bio, Inc. | 97.27% |
| Legend Biotech Corp. | 61.52% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 101.2% |
| Return on Assets | 90.37% |
| Return on Invested Capital | 98.47% |
| Profit Margin (Quarterly) | -507.2% |
| Operating Margin (Quarterly) | -567.2% |
| Return on Net Operating Assets | 14.15K% |